Alnylam Pharmaceuticals Inc. (ALNY)

$ 0.00
   
  • Closing Price Chg:
    $17.76
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 106.30m
  • Volume: 0
  • RiskGrade: 247

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 2,898.64 (28.08) (113.83)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 3,792.17 241.80 92.08¢ 455.6 n/a n/a n/a 0.0%
31-Dec-27 4,806.05 981.00 494.68¢ 84.8 0.2 +437% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

ALNY Market Data

Currency US Dollars
Share Price $ 419.55
Closing Price Change $ 17.76
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 106.30m
RiskGrade 247

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 8
Sell 0
Strong Sell 1
Total 32
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page